148 related articles for article (PubMed ID: 7460192)
1. Dose-dependence and related studies on the pharmacokinetics of misonidazole and desmethylmisonidazole in mice.
Workman P
Cancer Chemother Pharmacol; 1980; 5(1):27-37. PubMed ID: 7460192
[TBL] [Abstract][Full Text] [Related]
2. Effects of pretreatment with phenobarbitone and phenytoin on the pharmacokinetics and toxicity of phenytoin on the pharmacokinetics and toxicity of misonidazole in mice.
Workman P
Br J Cancer; 1979 Sep; 40(3):335-53. PubMed ID: 508562
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and tumour-penetration properties of the hypoxic cell radiosensitizer desmethylmisonidazole (Ro 05-Ro-9963) in dogs.
White RA; Workman P
Br J Cancer; 1980 Feb; 41(2):268-76. PubMed ID: 7370166
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumours.
Brown JM; Yu NY; Workman P
Br J Cancer; 1979 Mar; 39(3):310-20. PubMed ID: 465300
[TBL] [Abstract][Full Text] [Related]
5. Effects of the xanthine oxidase inhibitor allopurinol on the renal clearance of nitroimidazoles.
Workman P; White RA
Biochem Pharmacol; 1982 Oct; 31(19):3041-6. PubMed ID: 6897355
[TBL] [Abstract][Full Text] [Related]
6. Structure-pharmacokinetic relationships for misonidazole analogues in mice.
Workman P; Brown JM
Cancer Chemother Pharmacol; 1981; 6(1):39-49. PubMed ID: 7273265
[TBL] [Abstract][Full Text] [Related]
7. Desmethylmisonidazole (Ro 05-9963): clinical pharmacokinetics after multiple oral administration.
Stratford MR; Minchinton AI; Dische S; Saunders MI; Anderson P
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):377-9. PubMed ID: 7107355
[TBL] [Abstract][Full Text] [Related]
8. Effects of phenytoin, phenobarbital, and ascorbic acid on misonidazole elimination.
Williams K; Begg E; Wade D; O'Shea K
Clin Pharmacol Ther; 1983 Mar; 33(3):314-21. PubMed ID: 6825387
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of hypoxic cell radiosensitizers: a review.
Workman P
Cancer Clin Trials; 1980; 3(3):237-51. PubMed ID: 7438321
[TBL] [Abstract][Full Text] [Related]
10. The penetration of misonidazole into spontaneous canine tumours.
White RA; Workman P; Owen LN; Bleehen NM
Br J Cancer; 1979 Aug; 40(2):284-94. PubMed ID: 289406
[TBL] [Abstract][Full Text] [Related]
11. Kinetic aspects of misonidazole and its major metabolite in radiotherapy.
Meering PG; Gonzalez DG; Maes RA; van Peperzeel HA
Hum Toxicol; 1985 Jul; 4(4):425-34. PubMed ID: 4018823
[TBL] [Abstract][Full Text] [Related]
12. Distribution and tumour cytotoxicity of the radiosensitizer misonidazole (Ro-07-0582) in C57 mice.
Pedersen JE; Smith MR; Bugden RD; Peckham MJ
Br J Cancer; 1979 Apr; 39(4):429-33. PubMed ID: 444398
[TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetics of misonidazole in the dog.
White RA; Workman P; Freedman LS; Owen LN; Bleehen NM
Eur J Cancer (1965); 1979 Oct; 15(10):1233-42. PubMed ID: 520395
[No Abstract] [Full Text] [Related]
14. Studies on the O-demethylation of misonidazole by rat liver microsomes.
Shoemaker DD; McManus ME; Hoerauf R; Strong JM
Cancer Treat Rep; 1982 Jun; 66(6):1343-7. PubMed ID: 7083238
[TBL] [Abstract][Full Text] [Related]
15. The role of dexamethasone in the modification of misonidazole pharmacokinetics.
Jones DH; Bleehen NM; Workman P; Walton MI
Br J Cancer; 1983 Oct; 48(4):553-7. PubMed ID: 6626454
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of misonidazole enantiomers.
Williams KM
Clin Pharmacol Ther; 1984 Dec; 36(6):817-23. PubMed ID: 6499361
[TBL] [Abstract][Full Text] [Related]
17. Nonlinear pharmacokinetics of misonidazole and desmethylmisonidazole in the isolated perfused rat liver.
McManus ME; Monks A; Collins JM; White R; Strong JM
J Pharmacol Exp Ther; 1981 Dec; 219(3):669-74. PubMed ID: 7299690
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the fate of misonidazole (RO 07-0582) and its metabolite desmethylmisonidazole (RO 05-9963), two hypoxic cell radiosensitizers: penetration properties in tumor bearing rats.
Akel G; Canal P; Mockey E; Vandevoorde E; Laurent F; Soula G
J Pharmacol; 1983; 14(1):67-77. PubMed ID: 6834852
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics in mice and dogs of nitroimidazole radiosensitizers and chemosensitizers more lipophilic than misonidazole.
White R; Workman P; Owen L
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):473-6. PubMed ID: 7107369
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic considerations of misonidazole in therapeutics.
Matheson I; Plowman PN; Johnston A
Hum Toxicol; 1984 Feb; 3(1):29-36. PubMed ID: 6698564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
